R&D Evaluating methods targeting Protein-Protein Interactions Protein-protein interactions (PPIs) are becoming increasingly relevant in the pathology of many diseases, including cancer.
Views & Analysis Virtual reality therapy: The future of chronic pain manageme... Could virtual reality tools be effective in helping patients ‘unlearn’ their chronic pain?
R&D COVID-19: Celltrion's therapeutic option In just over a year, Celltrion Healthcare says it has identified and delivered a potential treatment for COVID-19.
Views & Analysis Taking steps towards a data-driven future for health and soc... A new policy paper promises to make it easier for innovators and developers to build and deploy tech and AI solution.
Views & Analysis Rare disease: industry, patients and tech join forces on dia... Takeda’s Adam Zaeske discusses how cross-sector collaboration is shaping a brighter future for rare disease diagnosis.
Views & Analysis Accelerating the adoption of innovation in the NHS Spreading innovation in the NHS is as much about fostering collaboration and building relationships as it is about designing new interventions and launching new technologies.
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
